Effect of eTansiyon smartphone application on hypertension control. (19th October 2022)

• Record Type: Journal Article
• Authors: Yilmaz, Emre; Uzuner, Arzu; Bajgora, Mensur; Dogan, Buket; Altikardes, Zehra A.; Kavakli Geris, Burçin; Akdeniz, Esra
• Is Part Of: Primary health care research & development. Volume 23(2022)
• Publication Date: 2022-10-19
• Subjects: blood pressure -- hypertension management -- mobile application -- patient-centred care -- primary care -- smartphone; Family medicine -- Great Britain -- Periodicals; Primary care (Medicine) -- Great Britain -- Periodicals; 362.1094105
• DOI: 10.1017/S146342362100058X
• Languages: English
• ISSNs: 1463-4236

Abstract

Abstract: Aim: To investigate the effectiveness of eTansiyon smartphone application in blood pressure control in patients with hypertension. Background: Global prevalence of hypertension and the burden of chronic illness care, especially in primary care, are increasing in world. We have developed eTansiyon to ensure the continuity of patient-physician relationship, so it may help to improve the lifestyle of patients with hypertension, increase their adherence to treatment and achieve the target blood pressure. Methods: This study was a non-randomized controlled study. The sample was selected by random sampling method among the patients registered in 6 Family Health Units (FHUs). Randomization was performed at the FHU level; the units were randomized to 4 control group (CG) and 2 intervention group (IG), so that randomization in this study was 2:1. Both groups were followed up for at least four months. In addition to CG, IG were provided to use eTansiyon . Obtained data were analysed to evaluate differences between groups at the beginning and end of the study, intra-group changes after follow-up and interaction between groups and follow-up period. Findings: The study was performed with 124 patients in CG and 61 patients in IG. At the end of the study, the average systolic blood pressure/diastolic blood pressure (SBP/DBP) of office and home was significantly lower in IG compared to CG ( P < 0.001, MD 9.5 mmHg; P = 0.007, MD 3.8 mmHg; P < 0.001, MD 10.6 mmHg; P < 0.001, MD 4.8 mmHg, respectively), and it was found that the proportion of people with target blood pressure in IG was significantly higher than CG ( P < 0.001, 49.2%( n = 30) and 22.6%( n = 28), respectively). Repeated measures ANOVA and generalized estimating equations results showed that follow-up period and interaction between groups were significant in terms of office and home SBP/DBP and target blood pressure level during follow-up period ( P < 0.001, P < 0.001, P < 0.001, P < 0.001, P < 0.024, respectively).